KLF15 and Hyperglycemia: This particular mechanism was confirmed in a streptozotocin-induced diabetic model, in which mice deficient in muscle-specific KLF15 showed protection against hyperglycemia-induced skeletal muscle atrophy, while streptozotocin treatment in wild-type mice showed muscle atrophy[49].